Phase 3 Ischaemic heart disease Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
The effect of Colchicine on Cardiovascular Outcomes in Acute Coronary Syndrome Study (The COLCARDIO-ACS Study)
AtherosclerosisIschaemic heart disease
University of Sydney3,000 enrolled16 locationsACTRN12616000400460
Completed
Phase 3
The Australian COPS trial - COlchicine in Patients with acute coronary Syndromes
Ischaemic heart disease
St. Vincent's Hospital Melbourne1,009 enrolled1 locationACTRN12615000861550